1. A phase I dose‐escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC‐223 in patients with advanced solid tumors or multiple myeloma. Issue 19 (15th July 2015) Authors: Bendell, Johanna C.; Kelley, Robin K.; Shih, Kent C.; Grabowsky, Jennifer A.; Bergsland, Emily; Jones, Suzanne; Martin, Thomas; Infante, Jeffrey R.; Mischel, Paul S.; Matsutani, Tomoo; Xu, Shuichan; Wong, Lilly; Liu, Yong; Wu, Xiaoling; Mortensen, Deborah S.; Chopra, Rajesh; Hege, Kristen; Munste... Journal: Cancer Issue: Volume 121:Issue 19(2015) Page Start: 3481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ACT-18 SHOULD THE DOSE OF TEMOZOLOMIDE BE DECREASED FOR PATIENTS WITH HIGH-GRADE GLIOMAS WHO ARE ON HEMODIALYSIS?. (16th December 2019) Authors: Muto, Jun; Matsutani, Tomoo; Matsuda, Ryosuke; Kinoshita, Masashi; Oikawa, Mitsuteru; Johan, Pallud; Adachi, Kazuhide; Hirose, Yuichi; Sasaki, Hikaru Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 2 Page Start: ii15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ACTR-37. SHORT-TERM BEVACIZUMAB FOR RECURRENT GLIOBLASTOMAS. (5th November 2018) Authors: Matsutani, Tomoo; Hirono, Seiichiro; Iwadate, Yasuo Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CS-1 Cerebellar liponeurocytoma; Report of two cases with detailed metabolic, immunohistochemical, and genetic evaluations. (6th December 2021) Authors: Shimizu, Miyuki; Origuchi, Shinichi; Hirono, Seiichiro; Matsutani, Tomoo; Oota, Masayuki; Ikeda, Jun-Ichiro; Yokoo, Hideaki; Iwadate, Yasuo Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 6 Page Start: vi27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases. Issue 8 (August 2020) Authors: Yoshida, Yoichi; Zhang, Xiao-Meng; Wang, Hao; Machida, Toshio; Mine, Seiichiro; Kobayashi, Eiichi; Adachi, Akihiko; Matsutani, Tomoo; Kamitsukasa, Ikuo; Wada, Takeshi; Aotsuka, Akiyo; Iwase, Katsuro; Tomiyoshi, Go; Nakamura, Rika; Shinmen, Natsuko; Kuroda, Hideyuki; Takizawa, Hirotaka; Kashiwado,... Journal: Heliyon Issue: Volume 6:Issue 8(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. GCT-09. HEALTH AND SOCIAL ISSUES IN THE LONG-TERM GERM-CELL TUMOR SURVIVORS. (4th December 2020) Authors: Matsutani, Tomoo; Horiguchi, Kentaro; Ikegami, Shiro; Hirono, Seiichiro; Murai, Hisayuki; Saeki, Naokatsu; Iwadate, Yasuo Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 3 Page Start: iii329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. GCT-45. YOLK SAC TUMOR IN THE CEREBELLAR VERMIS - A CASE REPORT. (4th December 2020) Authors: Otake, Saori; Matsutani, Tomoo; Watanabe, Yousuke; Numata, Osamu; Ando, Ryo; Ochiai, Hidemasa; Junichiro, Ikeda; Iwadate, Yasuo Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 3 Page Start: iii337 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Intrinsic protective mechanisms of the neuron-glia network against glioma invasion. (April 2016) Authors: Iwadate, Yasuo; Fukuda, Kazumasa; Matsutani, Tomoo; Saeki, Naokatsu Journal: Journal of clinical neuroscience Issue: Volume 26(2016:Apr.) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography. Issue 9 (4th February 2016) Authors: Iwadate, Yasuo; Shinozaki, Natsuki; Matsutani, Tomoo; Uchino, Yoshio; Saeki, Naokatsu Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 87:Issue 9(2016) Page Start: 1016 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. MPC-8 Serum anti-zinc finger FYVE domain-containing protein 21 (ZFYVE21) autoantibody as a novel biomarker for oligodendroglioma IDH-mutant and 1p/19q co-deletion. (6th December 2021) Authors: Matsutani, Tomoo; Boshi, Zhang; Hirono, Seiichiro; Nagane, Motoo; Yoshino, Atsuo; Tanaka, Shouta; Ishikawa, Eiichi; Fukami, Shinziro; Yamaguchi, Fumio; Li, Shuyang; Watanabe, Yousuke; Kobayashi, Masayoshi; Ikegami, Shiro; Hiwasa, Takaki; Iwadate, Yasuo Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 6 Page Start: vi17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗